AI Vaccines & the Broader Shift in Vaccine Development
Jul 21st, 2026 in
Glossary
In June 2026, a vaccine designed almost entirely by computer simulation passed its first human safety trial. Researchers at the University of Cambridge and spinout DIOSynVax reported that theirAI-engineered "super-antigen"— built to protect against the entire Sarbecovirus[...]
